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Dietary therapy in uremia: The impact on nutrition and pro- More than 70 years ago, it was shown that a diet rich
gressive renal failure. in protein exerted adverse effects on the kidney function
Background. In rats with experimental chronic renal failure of rats [2]. In the 1930s, Chanutin and Ludewig studied(CRF), low-protein diets protect against histologic damage and
rats after subtotal nephrectomy and found that feedingimprove mortality. In CRF patients, low-protein diets amelio-
a high content of varying types of protein led to morerate uremic symptoms and certain CRF complications. Fortu-
nately, low-protein diets are nutritionally sound in CRF pa- severe hypertension, more interstitial damage and a
tients because they activate compensatory mechanisms that higher mortality [3]. In 1942, Farr and Smadel reported
conserve protein with a low-protein diet. These results do not the same results in rats with experimental serum nephri-determine if dietary protein restriction can slow the rate of
tis [4]. More recently, this theme was extended by show-progression of CRF or the time to dialysis.
ing that a low-protein diet prevents the adaptive increaseMethods. Reports evaluating low-protein diets and changes
in nutritional status and/or progression of CRF are analyzed in glomerular capillary pressure occuring in CRF and
for efficacy. The MDRD Study is reviewed in depth. it was proposed that this is the mechanism leading to
Results. When dietary compliance was achieved, the nutri-
progressive glomerular sclerosis [5]. Glomerular capil-tional status was unimpaired and progression was slowed. Stud-
lary hypertension was later linked to activation of theies with limited dietary compliance failed to find any beneficial
effect on progression. Problems in study design suggest caution renin-angiotensin system, another consequence of excess
before accepting the initial MDRD Study conclusion that di- dietary protein [6, 7]: angiotensin causes glomerular ef-
etary restriction does not slow progression. Subsequent analy- ferent arteriolar constriction, and hence glomerular hy-
ses of MDRD results indicate that protein restriction can slow
pertension, while aldosterone has nephrotoxic proper-progression of CRF.
ties. Another, perhaps allied theory is that proteinuriaConclusion. Evidence that dietary protein spontaneously
decreases in progressively uremic patients should not be con- initiates mechanisms that produce progressive interstitial
strued as an argument against the use of dietary therapy. Rather, nephritis [8]. Certainly, higher levels of proteinuria are
it is a persuasive argument to restrict dietary protein intake in associated with faster rates of loss of renal function [9],order to minimize CRF complications while preserving nutri-
and a low-protein diet reduces the degree of proteinuria,tional status. In patients with uremia or progression despite
but whether this is the mechanism for the protectiveother measures, dietary therapy should be started along with
monitoring for dietary compliance and nutritional adequacy. effect of a low-protein diet is unclear [10]. A third mecha-
nism involves hypertension-induced kidney damage. A
low-protein diet does restrict sodium intake, but it is
For more than a century, it has been known that a difficult to link a lower sodium intake to changes in the
protein-restricted diet can ameliorate many uremic degree of damage to the kidney. Thus, there is abundant
symptoms and during the past 30 years, dietary manipu- experimental evidence and even proposed mechanisms
lation was shown to prevent or treat some of the compli- to explain why too much dietary protein is associated
cations of chronic renal failure (CRF) including renal with progressive kidney damage. There also are caveats:
osteodystrophy, hypertension, electrolyte disturbances in a careful pair-feeding protocol, it was concluded that
and metabolic acidosis [1]. These improvements occur the amount of food and/or calories eaten is associated
because a low-protein diet invariably restricts the intake with kidney damage in rats; moreover, in other species
of phosphates, sodium, and acid that cause these compli- with CRF (e.g., baboons) a high-protein diet does not
cations. Less impressive evidence suggests that low-pro- accelerate renal insufficiency [11, 12].
tein diets can slow progression of renal insufficiency. In evaluating the effects of any therapy, including di-
etary manipulation, on the course of progressive renal
Key words: low-protein diets, progression, kidney, nutrition, diet insufficiency, it is important to remember two facts. The
first is that the loss of renal function in individual patientsÓ 2000 by the International Society of Nephrology
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is not chaotic but rather, usually predictable. This is based of predominantly vegetable protein supplemented with
on our finding in 1976 that the rate of loss of renal function a mixture of essential amino acids (EAA); or the same
in individual patients could be determined by plotting the VLPD diet supplemented with a mixture of EAA and
reciprocal of serum creatinine (SCr) against time [13]. the nitrogen-free analogs of amino acids (ketoacids). The
This means that creatinine clearance and glomerular fil- design of these diets requires attention to energy intake,
tration rate (GFR) are being lost in a predictable fashion vitamin and mineral requirements, etc. [24], but with
[14]. Even though there is controversy about the use of proper guidance, each yields neutral nitrogen balance
SCr in gauging the loss of renal function in patients being and is nutritionally sound during long-term therapy.
treated with low-protein diets, if there is long-term (e.g., Kopple and Coburn demonstrated that the dietary pro-
months to years) stability of SCr, there must be stability of tein requirement of patients with uncomplicated CRF is
creatinine clearance or GFR [2, 14]. The second finding is ,0.6 g protein/kg/day, the same as that for normal adults
that each patient has his/her own rate of loss of residual
[25] while others showed that supplemented VLPD dietsrenal function and hence, there is no rate that can be
produce nitrogen balance in CRF patients [22, 23]. Re-said to be characteristic of a specific kidney disease. For
garding long-term results, the Modification of Diet inexample, the rate of loss of renal function in diabetic
Renal Disease Trial (MDRD) showed that these dietspatients can vary more than 40-fold [15].
are not associated with biologically important changes
in body weight, mid-arm muscle circumference or serum
DIETARY MANIPULATION IN PATIENTS WITH proteins [26]. Importantly, no patient had to withdraw
PROGRESSIVE RENAL FAILURE from the MDRD trial because of impaired nutritional
When evaluating studies of dietary therapy and their status. Nitrogen balance is achieved with these low-pro-
impact on progressive renal failure, three questions tein diets because CRF patients like normal adults, acti-
should be considered: (1) does the diet cause malnutri- vate adaptive metabolic responses: they reduce the oxi-
tion; (2) has dietary adequacy been monitored and com- dation of EAA to ensure a sufficient EAA supply and
pliance achieved; and (3) has restricting the diet changed they decrease postprandial protein degradation (at least
the rate of loss of renal function? These questions can
as long as there is no catabolic stimulus such as metabolicbe evaluated using the following considerations.
acidosis) [22, 27].
Do low-protein diets cause malnutrition?
Monitoring dietary adequacy and complianceThe finding that dialysis patients often have low levels
Success with dietary therapy requires periodic assess-of serum proteins and evidence of malnutrition has led
ment of dietary compliance and nutritional status. Fortu-some to suggest that low-protein diets should be used
nately, there is a simple method for estimating the pro-cautiously or avoided and that dialysis of CRF patients
should be initiated early [16, 17]. It is true that if CRF tein intake of CRF patients [28]. The method is based
patients are not instructed in the composition, and how on urea nitrogen production because nitrogen derived
to accomplish dietary goals, there may well be a sponta- from dietary or endogenous protein is converted princi-
neous decrease in protein intake and deterioration of some pally to urea so the sum of urea excreted plus accumu-
nutritional indices [16]. Another worrisome report is the lated (i.e., the urea nitrogen appearance rate) closely
association between hypoalbuminemia and increased parallels protein intake. In contrast, the nitrogen in uri-
mortality in hemodialysis patients [18], but hypoalbumi- nary compounds such as creatinine, uric acid, ammonia,
nemia in these patients can be linked as much to evidence etc. and feces (i.e., nonurea nitrogen excretion) does not
of inflammation as it is to dietary inadequacy [19]. In vary significantly with protein intake: it averages 0.031
fact, CRF patients treated with low-protein diets were g nitrogen/kilogram ideal body weight/day [28]. To moni-
found to have an increase in serum protein concentrations
tor compliance, the 24 hour urea nitrogen excretion is
at the initiation of dietary therapy [20]. A low-protein diet
added to the estimated value of nonurea nitrogen excre-is also associated with improved survival of CRF patients
tion (0.031 3 body weight). The sum is equal to nitrogenwho subsequently began dialysis [21]. Finally, there is
intake if the patient is in steady-state and weight andabundant evidence that with proper implementation, a
serum urea nitrogen are constant. This method makeslow-protein diet yields neutral nitrogen balance and
it possible to evaluate compliance and hence, the efficacymaintenance of normal serum proteins and anthropo-
of a diet on changing progression.metric indices during long-term therapy [20, 22, 23]. Re-
Nutritional status is monitored by serial measurementsgarding nutritional adequacy, three diets have been used
of anthropometrics, serum albumin, and transferrin. Theto slow the progression of CRF: a low-protein diet pro-
assistance of a skilled dietician is required for successfulviding 0.6 g protein/kg ideal body weight/day; a very low-
protein diet (VLPD) containing ,0.3 g protein/kg/day monitoring of patients prescribed low-protein diets [2].
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PROTEIN RESTRICTION AND PROGRESSION protein [2, 34–36]. Predictably, there also was no benefit
of the low-protein regimens on progression of CRF.OF RENAL INSUFFICIENCY
There also is evidence that low-protein diets can slowUnsupplemented low-protein diets and progression
progression of diabetic nephropathy without compromis-
In one of the earliest trials, Maschio et al evaluated ing nutritional status. Walker et al examined the GFR of
three groups of patients: Groups I and II had initial SCr 19 patients with type I insulin-dependent diabetes mellitus
values of 1.6–2.7 and 2.9–5.4 mg/dL, respectively, and (IDDM), proteinuria and progressive CRF while they
were prescribed a diet containing 0.6 g/kg of predomi- consumed an unrestricted diet (1.13 g protein/kg/day)
nantly high-quality protein, 40 kcal/kg energy intake, [37]. When the patients were switched to a diet providing
,650 mg of phosphorus and 1.0–1.5 g of calcium; Group 0.67 g protein/kg/day, the loss of GFR slowed signifi-
III, the control group (initial SCr, 1.6–4.7 mg/dL), con- cantly (i.e., 0.61–0.14 mL/min/month) as did the rise in
sumed an unrestricted diet [29]. Although dietary com- albuminuria. These benefits were statistically significant
pliance was not rigorously evaluated, the loss of renal even after adjustment for differences in blood pressure,
function in Groups I and II was far slower than in Group energy intake and glycosylated hemoglobin levels. Raal
III. Subsequently, this group noted similar results after et al compared diets of 0.8 or $1.6 g protein/kg/day
an average of 54 months in a larger group of patients in a 6-month study of 32 type I IDDM patients with
[30]. Individuals who began a low-protein diet early had proteinuria and GFR of 50–66 mL/min/1.73 m2 [38]. With
a more favorable course and patients with interstitial the low-protein diet, there was no further decline in GFR
nephritis fared better than those with chronic glomerulo- and proteinuria significantly decreased but with the high
nephritis or polycystic kidney disease. The initial SCr, protein diet, patients lost GFR and proteinuria increased
level of proteinuria and blood pressure were indepen- even in this short-term study. Zeller et al reported results
dent risk factors for progression. of a randomized, prospective, controlled trial of Type I
Rosman et al reported the results of a prospective, diabetic patients with nephropathy treated for an aver-
randomized trial involving 149 patients followed for an age of 35 months [39]. Fifteen patients were assigned to
average of 24 months after being assigned to a low-protein a control diet of 1.0 while 20 patients were assigned to
or a control diet [31]. From the reported urea excretion a diet with 0.6 g protein/kg/day. Blood pressure and
values, the difference in protein intake between the pro- the degree of glycemic control were comparable in the
tein-restricted and control subjects averaged 18 g/day groups. The rate of decline in GFR (renal clearance of
[28] and even with this small change, there was significant 125I-iothalamate) was 4-fold slower with the low-protein
slowing of progression (3–5-fold slower) with the low- diet (23.1 versus 212.1 mL/yr, respectively; P , 0.02).
protein diet. Four years later, they reported on 153 of Although the mean arterial pressure was ,3 mm Hg
248 patients treated similarly [32]. There still was a de- lower in the low protein group (P , 0.05), the authors
tectable, albeit less significant, benefit of a low-protein attributed the slowing of progression to the low-protein
diet in slowing progression, but now the benefit was in diet since this small change and the similarities in gly-
patients with more advanced renal insufficiency, with cemic control and frequency of visits to the doctor could
glomerulonephritis and in men more than women. To not account for the benefit.
avoid the problems of using SCr, Ihle et al conducted an
Ketoacid-supplemented low-protein diets18-month prospective, randomized comparison of a low-
and progressionprotein and an unrestricted diet on changes in GFR
(plasma disappearance of tracer) [33]. Eight of the initial A VLPD diet supplemented with ketoacids also seems
72 patients with advanced CRF were excluded, as 3 with- to slow progression of CRF. Barsotti et al treated 27
drew voluntarily and 5 were excluded for noncompliance compliant, CRF patients who had a linear decrease in
with the diet or were taking medications that interfered their creatinine clearances using a regimen containing
with the analysis. End-stage renal disease (ESRD) devel- about 0.2 g protein/kg/day plus a supplement of the cal-
oped in 9 of 33 patients (27%) who were given an un- cium salts of ketoacids [40]. The loss of creatinine clear-
restricted diet, compared to only 2 of 31 (6%) of those ance was interrupted after beginning dietary therapy.
compliant with the protein-restricted diet (P , 0.05). Using another regimen of a VLPD plus ketoacids given
The average GFR decreased 60% in the control group as salts of the basic amino acids, ornithine and lysine
from 15 to 6 mL/min (P , 0.01) but minimally (14–12 over an average of 20 months, we found that the loss of
mL/min, P 5 NS) in the low-protein diet group. The renal function in 10 of 17 patients with well-defined rates
average protein intake calculated from urea excretion of progression (as assessed by changes in the reciprocal
was ,0.7 in the low protein group and ,0.95 g/kg/day of SCr) was halted [41]. Walser et al compared an EAA-
in the unrestricted group [2, 28]. based to a ketoacid-based, VLPD regimen in 12 patients
In contrast to these studies, there are results of trials with advanced CRF using a cross-over study design (i.e.,
KA then EAA and vice versa) [42]. The ketoacid regi-in which there was little or no change in the intake of
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men appeared to slow progression to a greater degree similar but there was no control group to determine if
dietary protein restriction was beneficial in patients withthan the EAA regimen. Although the number of patients
is small, it is important to emphasize that progression more advanced renal insufficiency.
These results might seem to strike the death knell forcan be delayed even in patients with advanced CRF.
the proposal that dietary protein restriction will slow
The Modification of Diet in Renal Disease Study progressive renal damage in CRF patients as it does
in rats with CRF. However, such an interpretation isThe NIH-sponsored MDRD Study contained the
largest number of patients participating in a trial of the complicated by several factors. Firstly, the sample size
was based on the assumption that GFR would declineinfluence of low-protein diets on progression of CRF
[43]. This multicenter, randomized, prospective trial was ,6 mL/min/yr in patients eating an unrestricted diet and
maintaining their usual blood pressure. Overall, how-designed to evaluate whether two levels of blood pres-
sure (usual mean arterial pressure [MAP] 5 107 mm Hg ever, progression was ,30% slower than expected,
dampening the power to detect a benefit of the diet. Thisor ,140/90 versus low MAP 5 92 mm Hg or ,125/75)
and different levels of protein intake would slow the problem was compounded by two additional factors: (1)
patients enrolled in the MDRD Study did not have toprogression of CRF; diabetics were excluded. Hyperten-
sion was treated with angiotensin-converting enzyme in- exhibit evidence of progressive renal insufficiency and
approximately 15% of the Study A control group hadhibitors (ACEi) or other drugs in an unregulated fashion.
In Study A, 585 patients with GFRs between 25 and 55 no evidence of loss of GFR making it impossible to
demonstrate slowing of progression. (2) A dispropor-mL/min were randomly assigned to their usual or a low-
protein diet (1.3 versus 0.58 g protein/kg/day); in Study tionate number of patients (,20%) had polycystic kid-
ney disease, and progression in these patients appearedB, 255 patients with GFRs between 13 and 24 mL/min
were randomly assigned to a low or a very low-protein to be unaffected by dietary means or aggressive treat-
ment of hypertension. Inclusion of these patients coulddiet (0.58 versus 0.28 g protein/kg/day). In Study B, the
VLPD diet was supplemented with ketoacids but no obscure a benefit of the diet on progression in patients
with other kidney diseases. Secondly, the use of ACEicontrol diet was included for comparison with the low
protein regimens. Protein intake assessed [28] and GFR could make the benefit of a low-protein diet more diffi-
cult to detect. Another complication was in the mixture(renal clearance of 125I-iothalamate) was measured every
4 months over an average follow-up of 2.2 years. Compli- of ketoacids in the MDRD Study since it differed from
the mixture that was reported to slow progression inance with the prescribed protein intake was quite good
(Study A; 1.11 6 0.19 versus 0.73 6 0.15; Study B, 0.69 6 other studies [41, 42, 44]. Thirdly, the initial rapid GFR
decline in Study A patients assigned to the low protein0.12 versus 0.46 6 0.15 g protein/kg/day, [mean 6 SD
at 2 years follow-up]). During the first four months, renal and low blood pressure groups was unexpected and could
have obscured a slowing of progression subsequently.function declined more rapidly in Study A patients as-
signed to the low protein and low blood pressure groups This raises the issue of the short (2.2 years) duration of
the study; in an evaluation of another metabolic interven-(P 5 0.004 and , 0.01, respectively). Thereafter, the
rate of decline in GFR was 28% slower in the low protein tion on kidney function (the DCCT Trial [45]), strict
glycemic control exerted no suppressive effect for 4 years(P 5 0.009) and 29% slower in the low blood pressure
group (P 5 0.006). However, when the results were ana- but then a benefit on proteinuria was obvious. Finally,
there was no˙ control¨ diet in Study B, so the results neitherlyzed from the initial to the final GFR values and compli-
ance was ignored in an intention-to-treat analysis, the support nor refute a benefit of dietary protein restriction
in patients with advanced renal insufficiency.projected decline in GFR did not differ significantly be-
tween diet or blood pressure groups. In the analysis of These factors make it unwise to conclude that the
MDRD Study proves that dietary manipulation doespatients with more advanced CRF (Study B), the loss
of GFR was 19% slower in the very low protein com- not slow progression of CRF. As discussed, this type of
conclusion does not address the central hypothesis thatpared to the low protein group (P 5 0.065) but the
cumulative incidence of end-stage renal disease or death eating a low-protein diet can slow the progression of
CRF. In fact, when MDRD results were analyzed basedwas not different. Notably, the lower blood pressure
groups also did not exhibit slowing of progression in on the amount of protein actually consumed, a benefit of
dietary protein restriction in Study B patients was obvious:either Study A or Study B, with the exception that pro-
gression was significantly slower when there was . 1 g each 0.2 g/kg/d reduction in protein intake was associated
with a 29% slower rate of loss of GFR and a 51% prolon-proteinuria/day. The authors concluded that with moder-
ate CRF (Study A), the slower decline in renal function gation in the time to dialysis (P , 0.01) [46, 47]. Although
no independent influence of the ketoacid regimen wasthat began 4 months after beginning the low-protein diet
suggests a small benefit of protein restriction. In Study detected, this conclusion might differ if another ketoacid
mixture were used in the MDRD Study [44]. RegardingB, they concluded that the effects of the two diets were
Mitch: Dietary therapy in uremiaS-42
6. Daniels BS, Hostetter TH: Effects of dietary protein intake onthe ability to make generalized conclusions, there also
vasoactive hormones. Am J Physiol 258:F1095–F1100, 1990
are the problems discussed about the reliability of the 7. Rosenberg ME, Chmielewski D, Hostetter TH: Effect of dietary
protein on rat renin and angiotensinogen expression. J Clin Investanalysis: the meta-analysis technique based on combin-
85:1144–1149, 1990ing results from several studies provides a different an-
8. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature
swer. Fouque et al used this technique to evaluate six of renal disease progression. Kidney Int 51:2–15, 1997
9. The GISEN Group: Randomized placebo-controlled trial of effectclinical trials that included 890 nondiabetic, randomly
of ramipril on decline in glomerular filtration rate and risk ofassigned patients who were followed for at least one year
terminal renal failure in proteinuric, non-diabetic nephropathy.
[48]. They concluded that 5 of the 6 trials showed a Lancet 349:1857–1863, 1997
10. Kaysen GA. The nephrotic syndrome: nutritional consequencesreduction in the number of renal “deaths” (61 for low-
and dietary management, in Handbook of Nutrition and the Kidney,protein diet groups versus 95 for control groups) and
3rd Edn, edited by Mitch WE, Klahr S. Philadelphia, Lippincott-
calculated an odds-ratio for renal death of 0.54 in patients Raven, 1998: pp. 201–212
11. Tapp DC, Wortham WG, Addison JF, Hammonds DN, Barnesprescribed a low-protein diet (P , 0.002), corresponding
JL, Venkatachalam MA: Food restriction retards body growthto a 46% decrease in the likelihood of kidney failure.
and prevents end-stage renal pathology in remnant kidneys of rats
Pedrini et al extended these results by including MDRD regardless of protein intake. Lab Invest 60:184–195, 1989
12. Bourgoignie JJ, Gavellas G, Sabnis SG, Antonovych TT: Effectdata: in nondiabetic patients, a low-protein diet was asso-
of protein diets on the renal function of baboons (Papio hama-ciated with a 33% reduction in the risk of renal failure
dryas) with remnant kidneys: a 5-year follow-up. Am J Kidney Dis
or death (P , 0.007) and in diabetic patients, the diet 23:199–204, 1994
13. Mitch WE, Buffington GA, Lemann J, Walser M: A simplereduced the risk of further kidney damage (a decrease
method of estimating progression of chronic renal failure. Lancetin creatinine clearance or GFR or an increase in protein-
2:1326–1328, 1976
uria) by 46% (P , 0.001) [49]. They also noted problems 14. Mitch WE: Nutritional therapy and progression of chronic renal
insufficiency, in Handbook of Nutrition and the Kidney, 3rd Edn,with the design of the MDRD Study and estimated that
edited by Mitch WE, Klahr S. Philadelphia, Lippincott-Raven,at least 1000 patients were needed to detect a 33% reduc-
1998, pp. 237–252
tion in the risk of renal failure or death. 15. Jones RH, Hayakawa H, MacKay JD, Parsons V, Watkins PF:
The progression of diabetic nephropathy. Lancet 1:1105–1106, 1979In principle, a low-protein diet could reduce the risk
16. Ikizler TA, Greene JH, Wingard RL, Hakim RM, Parker RA:of renal failure either by slowing the progression of renal
Spontaneous dietary protein intake during progression of chronic
disease and by ameliorating uremic symptoms. Based on renal failure. J Am Soc Nephrol 6:1386–1391, 1995
17. Hakim RM, Lazarus JM: Initiation of dialysis. J Am Soc Nephrolthe secondary analyzes of the MDRD study showing
6:1319–1320, 1995that there is a strong correlation between actual protein
18. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The
intake and both the rate of GFR loss and dialysis entry, predictive value of commonly measured variables and an evalua-
tion of the death rate differences among facilities. Am J Kidneyprotection of residual renal function is likely to be one
Dis 15:458–482, 1990mechanism. The other factor is also important: attention
19. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am
to the diet can postpone the need for dialysis without Soc Nephrol 9:2368–2376, 1998
compromising nutritional status [50]. In short, it seems 20. Walser M: Does prolonged protein restriction preceding dialysis
lead to protein malnutrition at the onset of dialysis? Kidney Intlikely that both mechanisms probably contribute to the
44:1139–1144, 1993beneficial effect of a low-protein diet. 21. Coresh J, Walser M, Hill S: Survival on dialysis among chronic
renal failure patients treated with a supplemented low-protein diet
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